大阪大学消化器外科 - Osaka University...tumor thrombus in the major trunk. 2015 Shanghai...

大阪大学消化器外科

主演者姓名共同演者全員演題名学会名開催地発表年開催月備考

1 Mori M. Richard D. Schulick Joint SSO/JSGS Symposium:

Management of Bile Duct

Tumors(MOC)

SSO's 68th Annual Cancer

Symposium

Houston,

U.S.A.

2015 3 モデレーター

2 Doki Y. Current status and future

perspective of esophageal

cancer treatment in Japan

2015ANNUAL MEETING OF

ZHEJIANG ASSOCIATION

OF SURGICAL ONCOLOGY

THE FIRST QIANJIANG

INTERNATIONAL SUMMIT

SYMPOSIUM OF SURGICAL

ONCOLOGY

Hangzhou,

China

2015 9 講演

3 Eguchi H. Incidence and implication of

extrapancreatic neoplasms in

patients with IPMN

The 10th International Single

Topic Symposium (ISTS

2015)

Seoul, Korea 2015 9 口演

4 Nakajima K Development of Medical

Devices based on "unmet

clinical needs": Are we on the

right track?

MEI-Center Summer School Osaka 2015 8 招待講演

5 Nakajima K CO2 stabilizer for endoscopic

diagnosis and interventions.

6th ENDOCOURSE MILAN Milano 2015 11 招待講演

6 Nakajima K A novel portable endoscopy

system for universal access.

International NOTES

W.I.D.E.R.

Barcelona 2015 11 招待講演

7 Nakajima K Session with video

transmission from the

Research Institute and Clinical

Department Working Group

International NOTES

W.I.D.E.R.

Barcelona 2015 11 コメンテーター

8 Nakajima K R&D of Medical Devices via

Collaboration between AIIMS

and Osaka University

AIIMS Surgical Week Delhi 2015 3 招待講演

9 Nakajima K Next Generation Endoscopy

through Surgeon's Eyes

DDW Washington

D.C.

2015 5 シンポジウム

10 Hata T. Takemasa I., Uemura M.,

Nishimura J., Hata T.,

Mizushima T.,

Yamamoto H., Doki Y.,

Mori M.

SAFETY OF LAPAROSCOPIC

LOWER ANTERIOR

RESECTION AFTER

NEO-ADJUVANT CapeOx

23rd International Congress

of the EAES

Bucharest

Romania

2015 6 示説

11 Kurokawa Y. Doki Y. Bursectomy

for gastric cancer

Korea International Gastric

Cancer Week 2015

Jeju, Korea 2015 4 シンポジウム

12 Kurokawa Y. Bursectomy and laparoscopic

trials in Japan

11th International Gastric

Cancer Congress

Sao Paulo 2015 6 シンポジウム

13 Takahashi T. Hirota S., Nishida T.,

Miyazaki Y., Makino T.,

Kurokawa Y.,

Yamasaki M., Nakajima K.,

Takiguchi S., Mori M.,

Doki Y.

KIT and PDGFRA mutations of

gastrointestinal stromal tumor

3rd International Conference

of Federation of Asian Clinical

Oncology

Kyoto 2015 10 示説

14 Takahashi T. Nakatsuka R., Hara H.,

Higashi S., Miyazaki Y.,

Kurokawa Y., Takiguchi S.,

Mori M., Doki Y.,

Nakajima K.

Feasibility study of real-time

intestinal bloodstream

evaluation using probe based

confocal laser endomicroscopy

in porcine intestinal ischemia

models

Asian Pacific Digestive Week Taipei 2015 12 示説

15 Wada H. Eguchi H., Marubashi S.,

Tomimaru Y.,

Tomokuni A., Asaoka T.,

Kawamoto K.,

Umeshita K., Nagano H.,

Doki Y., Mori M.

Selection criteria for hepatic

resection to hepatocellular

carcinoma with multiple

nodules at intermediate stage

of BCLC.

The 6th Asia-Pacific Primary

Liver Cancer Expert Meeting

Osaka 2015 7 示説

16 Wada H. Eguchi H., Noda T.,

Ogawa H., Yamada D.,

Kawamoto K., Gotoh K.,

Umeshita K., Nagano H.,

Doki Y., Mori M.

Treatment strategy for

advanced hepatocellular

carcinoma with portal vein

tumor thrombus in the major

trunk.

2015 Shanghai International

Forum of Liver Cancer with

Portal Vein Tumor

Thrombosis (PVTT)

Shanghai,

China

2015 10 招待講演

17 Nishimura J. Satoh T., Fukunaga M.,

Takemoto H., Nakata K.,

Ide Y., Fukuzaki T.,

Kudo T., Miyake Y.,

Yasui M., Morita S.,

Sakai D., Uemura M.,

Hata T., Takemasa I.,

Mizushima T., Ohno Y.,

Yamamoto H.,

Sekimoto M., Nedu R.,

Doki Y., Mori M.

A phase III trial of aprepitant in

colorectal cancer patients

receiving oxaliplatin-based

chemotherapy (SENRI Trial)

17th World congress on

Gastrointestinal Cancer

(ESMO)

Barcelona,

Spain

2015 7 口演

18 Noda T. Wada H., Eguchi H.,

Ogawa H., Yamada D.,

Asaoka T., Kawamoto K.,

Gotoh K., Umeshita K.,

Doki Y., Mori M.

Surgical Outcome of

Laparoscopic Liver Resection

for Hepatocellular Carcinoma

The 6th Asia-Pacific Primary

Liver Cancer Expert Meeting

Osaka 2015 7 口演

19 Miyazaki Y. Takiguchi S., Shinno N.,

Yanagimoto Y.,

Takahashi T.,

Kurokawa Y., Makino T.,


Mori M., Doki Y.

Clinical correlation between

ghrelin factors and utcomes of

sleeve gastrectomy for

morbidly obese patients

The 12th Asia-Pacific

Congress of Endoscopic and

Laparoscopic Surgery

Daegu,

Korea

2015 9 示説

20 Tomimaru Y. Surgical management for

advanced hepatocellular

carcinoma with portal vein

tumor thrombus in the major

trunk

American College of

Surgeons 101st Clinical

Congress

Chicago 2015 10 パネルディス

カッション

21 Colvin H. Nishida N., Koseki J.,

Konno M., Kawamoto K.,

Doki Y., Mori M., Ishii H.

The Relationship Between D-

and L-2-Hydroxyglutarate and

Epithelial-Mesenchymal

Transition

Cell Symposium: Stem Cell

Epigenetics

Melia Sitges,

Spain

2015 9 示説

22 Hara H. Nakatsuka R.,

Takahashi T., Serada S.,

Fujimoto M., Miyazaki Y.,

Makino T., Kurokawa Y.,

Yamasaki M., Miyata H.,

Nakajima K., Takiguchi S.,

Mori M., Doki Y., Naka T.

Gene therapy for esophageal

squamous cell carcinoma using

SOCS-1 expressing Adenoviral

Vector

American Association for

Cancer Research Annual

Meeting 2015

Pennsylvania

Convention

Center

Philadelphia,

Pa.

2015 4 示説

23 Hara H. Takahashi T.,

Nakatsuka R., Higashi S.,

Miyazaki Y., Kurokawa Y.,


Doki Y., Nakajima K.

Feasibility and safety of optical

biopsy using probe based

confocal laser endomicroscopy

for peritoneal dissemination


24 Inoue A. Yamamoto H., Uemura M.,


Mizushima T., Doki Y.,

Mori M.

MiR-29b is a Novel Potential

Prognostic Marker and

Regulates Tumor Progression

in Colorectal Cancer.

SSO's 68th Annual Cancer

Symposium

Houston,

Texas, USA

2015 3 示説

25 Kanemura T. Kurokawa Y., Miyazaki Y.,

Makino T., Takahashi T.,



Doki Y.

The impact of postoperative

complications and delays in

chemotherapy on disease

recurrence in gastric cancer


Cancer Congress

Sao Paulo 2015 6 示説

26 Miyo M. Takemasa I., Uemura M.,


Mizushima T.,

Yamamoto H., Doki Y.,

Mori M.

UMBILICAL DIVERTING

LOOP-ILEOSTOMY IN

LAPAROSCOPIC RECTAL

SURGERY


of the EAES

Bucharest

Romania

2015 6 示説

27 Nagase H. Nishikawa H., Wada H.,

Saito T., Nagano Y.,

Sugiyama D., Atarashi K.,

Maeda Y., Sato E.,

Tanoue T., Suda W.,

Morita H., Hattori M.,

Honda K., Mori M., Doki Y.,

Sakaguchi S.

Microbiota modulate colorectal

cancer microenvironment and

develop two immunologically

different tumors

International Conference of

Cancer Immunotherapy and

Macrophages 2015

Tokyo 2015 7 口演

28 Wada N. Kurokawa Y., Miyazaki Y.,




Doki Y.

Clinical usefulness of

preoperative positron emission

tomography-computed

tomography in esophagogastric

junction adenocarcinoma


Cancer Congress

Sao Paulo 2015 6 口演

29 Yanagimoto Y. Takiguchi S., Miyazaki Y.,

Takahashi T.,



Mori M., Doki Y.

Comparative study of clinical

outcomes between

laparoscopic proximal

gastrectomy (LPG) and

laparoscopic total gastrectomy

(LATG) for proximal gastric

cancer


Cancer Congress

Sao Paulo 2015 6 口演

30 Yanagimoto Y. Takiguchi S., Miyazaki Y.,

Takahashi T.,



Mori M., Doki Y.

Comparative study of clinical

outcomes between

laparoscopic proximal

gastrectomy (LPG) and

laparoscopic total gastrectomy

(LATG) for proximal gastric

cancer




Daegu,

Korea

2015 9 示説

31 Takeoka T. Nagase H., Miyazaki Y.,

Takahashi T.,


Yamasaki M., Takiguchi S.,

Mori M., Doki Y., Wada H.

NY-ESO-1protein cancer

vaccine TLR3 and 4 agonists

CRI-CIMT-EATI-AACR -

The Inaugural International

Cancer Immunotherapy

Conference: Translating

Science into Survival

New York 2015 9 示説

32 Higashi S. Takahashi T., Miyazaki Y.,

Makino T., Kurokawa Y.,

Yamasaki M., Takiguchi S.,

Mori M., Doki Y.,

Nakajima K.

Dynamics of intraluminal

pressure of the esophagus

ESD in preclinical experiments


33 Shinno N. Takiguchi S., Miyazaki Y.,


Kurokawa Y.,


Mori M., Doki Y.

Comparison of various

reconstruction procedures for

patients with Siewert type II

cancer




Daegu,

Korea

2015 9 示説

34 Sugase T. The relationship between the

peripancreatic anatomical

position and postoperative

drain amylase value in

laparoscopic gastrectomy




Daegu,

Korea

2015 9 示説

医療法人彩樹守口敬任会病院


1 Saito S Sekido H, Yoshida S,

Isayama H, Matsuzawa T,

Kuwai T, Maetani I,

Shimada M, Yamada T,

Tomita M, Koizumi K, Hirata

N, Kanazawa H, Ikeda S,

Konishi K, Hirakawa T, Kyo

R, Enomoto T, Saida Y

A prospective multicenter study

of self-expandable metallic

stents as a bridge to surgery for

malignant colorectal obstruction

in Japan: efficacy and safety in

313 patients

Society of American

Gastrointestinal and

Endoscopic Surgeons 2015

アメリカ 2015 4 Oral

2 Sasai Y Maeda T, Suzuki A,

Hirokawa M

Abundant Megakaryocytes in

Fine-Needle Aspirates of the

Thyroid: A Report of Two cases

15th international thyroid

congress

アメリカ 2015 10 Poster

大阪警察病院


1 Tanemura M ＩｒｅｉＴ，ＩｎｏｕｅＭ，

ＹａｍａｓｈｉｔａＳ，

ＦｕｒｕｋａｗａＫ，

ＷａｋａｓｕｇｉＭ，

ＫｉｓｈｉＫ，ＮａｇａｎｏＨ，

ＡｋａｍａｔｓｕＨ，

ＵｒａｔａＹ，ＨａｔａｎａｋａＮ，

ＭｏｒｉＭ，ＤｏｋｉＹ．

Ｔｈｅｄｅｔｅｃｔｉｏｎｏｆｖｉａｂｌｌｅ

ｈｕｍａｎｃｉｒｃｕｌａｔｉｎｇｔｕｍｏｒ

ｃｅｌｌｓ（ｖ-ｈＣＴＣｓ）ｉｎｒｅｓｅｃｔａｂ

ｌｅｐａｎｃｒｅａｔｉｃｃａｎｃｅｒｉｎｄｕ

ｃｅｄｂｙｎｅｏａｄｊｕｖａｎｔｃｈｅ

ｍｏｒａｄｉｏｔｈｅｒａｐｙ（ＮＡＣＲＴ）

ｕｓｉｎｇ

ｇｅｍｃｉｔａｂｉｎｅ，Ｓ-1ａｎｄｉｎｔｅｎ

ｓｉｔｙ-ｍｏｄｕｌａｔｅｄｒａｄｉｏｔｈｅｒａ

ｐｙ（ＩＭＲＴ）

Ａｍｅｒｉｃａｎ

Ａｓｓｏｃｉａｔｉｏｎ

ｆｏｒＣａｎｃｅｒ

Ｒｅｓｅａｒｃｈ

ＰＨＩＬＡ

ＤＥＬＰＨ

ＩＡ

2015 4 Poster

2 Ｆurukawa ＫＭａｓａｈｉｒｏＴ，ＥｉｊｉＭ，

ＨｉｒｏａｋｉＮ，ＭａｓａｋｉＷ，

ＴｏｒｕＭ，

ＭｉｓｔｕｙｏｓｈｉＴ，

ＫｅｎｔａｒｏＫ，ＨｉｒｏｋｉＡ，

ＨｉｄｅｔｏｓｈｉＥ，

ＫａｔｓｕｙｏｓｈｉＭ，

ＭａｓａｋｉＭ，

ＹｕｉｃｈｉｒｏＤ．

Ｎｏｖｅｌｉｍｍｕｎｏｔｈｅｒａｐｙｕｓｉ

ｎｇａｔｕｍｏｒｌｙｓａｔｅｖａｃｃｉｎ

ｅｗｉｔｈ α-ｇａｌｅｐｉｔｏｐｅｓａｇ

ａｉｎｓｔｐａｎｃｒｅａｔｉｃｃａｎｃａｒ

Ａｍｅｒｉｃａｎ

Ａｓｓｏｃｉａｔｉｏｎ

ｆｏｒＣａｎｃｅｒ

Ｒｅｓｅａｒｃｈ

ＰＨＩＬＡ

ＤＥＬＰＨ

ＩＡ

2015 4 Poster

紀南病院


1 Miyazaki S Nagaoka M, Yamabe K Estimation of performance of

surgery by means of obesity

index of the patients with

gastric cancer performed distal

gastrectomy

46th World Congress of

Surgery

Bankoq 2015 8 示説

健康保険組合連合会大阪中央病院


1 Souma Y Yumiba T, Hamada T,

Kobayashi T, Ohashi S

Surgical outcomes of totally

laparoscopic distal gastrectomy

with intracorporeal

reconstruction using linear

stapler in our hospital: A

comparison with extracorporeal

reconstruction.

11th Congress of the

International Gastric

CancerAssociation

Sao

Paulo

2015 6 示説

大手前病院


1 Tamagawa H Mizushima T, Matsuda C,

Murata K, Fukunaga M,

Ohta H, Hasegawa J,

Tsujie M, Fukuzaki T,

Hata T, Takemasa I,

Ikeda M, Yamamoto H,

Sekimoto M, Nezu R,

Doki Y, Mori M

Phase II Study of Oral

Tegfur/Uracil and Leucovorin

plus Bevacizumab as a

First-Line Therapy for Elderly

Patients with Advanced or

Metastatic Colorectal Cancer

World Congress on

Gastrointestinal Cancer 2015

Barcelo

na,

Spain

2015 7 示説

2 Fujita Y Yamazaki K, Oba MS,

Muro K, Negoro Y,

Yoshida M, Suyama K,

Kurimoto T, Sugimoto N,

Seki N, Sato M, Ebi M,

Tamagawa H, Ueda S,

Tamura T, Boku N, Hyodo I,

Yamanaka T, Tsurutani J,

Nishio K

Exploratory analysis of

predictive biomarkers of

oxaliplatin versus irinotecan in

combination with bevacizumab

for patients with metastatic

colorectal cancer in

WJOG4407G study

European Cancer Congress

2015

Vienna,

Austria

2015 9 示説

3 Tsuji Y Yamazaki K, Saito Oba M,

Sakai K, Nagase M, Ueda S,

Tamagawa H, Tamura T,

Moriwaki T, Murata K,

Taira K, Denda T, Funai S,

Tsuda T, Tsushima T,

Boku N, Hyodo I,

Yamanaka T, Tsurutani J,

Nishio K

Predictive biomarker analysis of

early tumor shrinkage induced

by FOLFIRI+Bev for patients

with metastatic colorectal

cancer in WJOG4407G study


2015

Vienna,

Austria

2015 9 示説

市立池田病院


1 Hirofumi Ota Ikenaga M., Okamura S.,

Miyake Y., Fujie Y., Kim H.,

Ikeda K, Ikeda M,

Murata K., Hasegawa J,

Mizushima T.,

Yamamoto H., Takemasa I.,

Sekimoto M., Nezu R.,

Doki Y., Mori M.

A Multi-institutional Controlled

Study on Safety and Efficacy

of an Enhanced Recovery After

Surgery(ERAS) Protocol to

Patients with Colon Cancer

World Congress of Enhanced

Recovery After Surgery and

Perioperative Medicine

Washington

DC, USA

2015 5 示説

市立貝塚病院


1 Tsujinaka T Yamamoto K, Fukuda Y,

Tanizaki N, Kurata M

SERUM ZINC LEVELS IN

PATIENTS WITH

GASTROINTESTINAL

CANCER RECEIVING

CHEMOTHERAPY IN

RELATION TO

GASTROINTESTINAL

TOXICITIES

37ｔｈ ESPEN Congress on

Clinical Nutrition &

Metabolism

Lisbon

Portugal

2015 9 示説

2 Fujitani K Shishido Y, Yamamoto K,

Hirao M, Tsujinaka T,

Sekimoto M.

C-reactive protein on

postoperative day 3 as a

predictor of infectious

complications following gastric

cancer resection

2015 Gastrointestinal Cancer

Symposium

San

Francisco

2015 1 示説

3 Nishikawa K Imamura H, Kawase T,

Gotoh M, Kimura Y,

Ueda S, Matsuyama J,

Kawada J, Sugimoto N,

Fujita J, Tamura T,

Fukushima N, Sakai D,

Shimokawa T,

Kurokawa Y, Satoh T,

Tsujinaka T, Furukawa H

A randomized phase II factorial

design trial of CPT-11 versus

PTX versus each combination

with S-1 in patients with

advanced gastric cancer

refractory to S-1: Final results

of OGSG0701

2015 Gastrointestinal

Cancers Symposium

San

Francisco

2015 1 示説

4 Yamamoto K Fukuda Y, Tsujinaka T,

Nishikawa K, Hirao M,

Nagatsuma Y,

Nakayama T, Tanikawa S,

Maeda S, Miyake M,

Hama N, Miyamoto A,

Ikeda M, Nakamori S,

Sekimoto M

Sarcopenia is associated with

severe postoperative

complications in elderly gastric

cancer patients undergoing

gastrectomy



Metabolism

Lisbon

Portugal

2015 9 示説

5 Fukuda Y Yamamoto K, Tsujinaka T,

Nishikawa K

Optimal preoperative nutritional

support for malnourished

patients with gastric cancer

undergoing gastrectomy



Metabolism

Lisbon

Portugal

2015 9 示説

6 Makihara K Azuma S, Ueno H,

Nakata I, Yamamoto K,


Fujitani K, Tsujinaka T

Effect of renal function on

continuation of S-1 adjuvant

chemotherapy in gastric cancer

patients


Cancers Symposium

San

Francisco

2015 1 示説

7 Hasegawa H Fujitani K, Sugimoto A,

Nakazuru S, Hirao M,

Tsujinaka T, Mita E

Optimal indications for

palliative chemotherapy in

elderly patients with metastatic

or recurrent gastric cancer


Cancers Symposium

San

Francisco

2015 1 示説

8 Yang HK Fujitani K, Mizusawa J,

Kim YW, Terashima M,

Han SU, Iwasaki Y,

Hyung WJ, Takagane A,

Park BJ, Tsujinaka T,

Hahn S, Sasako M,

Bang YJ

Randomaized controlled trial

comparing gastrectomy plus

chemotherapy with

chemotherapy alone in

advanced gastric cancer with a

single non-curable

fanctor:REGATTA

trial(JCOG0708/KGCA01)

ASCO 2015 Chicago 2015 5 シンポジウム

堺市立総合医療センター


1 Kimura Y Takiguchi S, Mikami J,

Makari Y, Hirao M,

Imamura H, Fujita J,

Kobayashi K, Fujiwara Y,

Tamura S, Kurokawa Y,

Mori M, Doki Y

Comparison of 5-year

postoperative effects after

Billroth I and Roux-en-Y

reconstruction following distal

gastrectomy for gastric cancer:

results from a

multi-institutional RCT

The European Cancer

Congress 2015

Vienna

(Austria)

2015 9 一般ポスター

2 Masuishi T Kawase T, Nishikawa K,

Kunisaki C, Matsusaka S,

Segawa Y, Nakamura M,

Sasaki K, Nagao N,

Tshuji A, Yuasa Y, Asami S,

Takeuchi M, Furukawa H,

Fujii M, Nakajima T

Multicenter phase Ⅱ study of

trastuzumab

with S-1 alone in elderly

patients with HER-2 positive


(JACCRO GC-06)

2015 American Society of

Clinical Oncology

(ASCO)-Gastrointestinal

Cancers Symposium

San

Francisc

o (USA)


3 Nishikawa K Imamura H, Kawase T,

Gotoh M, Kimura Y, Ueda S,

Matsuyama J, Sugimoto N,

Fujita J, Tamura T,

Fukushima N, Sakai D,

Shimokawa T, Kurokawa Y,

Satoh T, Tsujinaka T,

Furukawa H

A randomized phase II factorial

design clinical trial of CPT-11

vs PTX vs each combination

chemotherapy with S-1 in

patients with advanced gastric

cancer refractory to S-1 or S-1

plus platinum.: Final results of

OGSG0701


Clinical Oncology


Cancers Symposium

San

Francisc

o (USA)


4 Ito S Sano S, Katayama H,

Mizusawa J, Takahari D,

Sasako M, Katai H,

Tanaka Y, Kinoshita T,

Terashima M, Nashimoto A,

Yamaue H, Fukushima N,

Yamada M, Fujiwara Y,

Kimura Y, Azuma T,

Yoshimura T

A phase II study of neoadjuvant

chemotherapy (NAC) with

docetaxel, cisplatin, and S-1

(DCS) followed by gastrectomy

with D2 plus para-aortic lymph

node (PAN) dissection for

gastric cancer with extensive

lymph node metastasis (ELM):

JCOG1002.


Clinical Oncology


Cancers Symposium

San

Francisc

o (USA)


5 Takahari D Ito S, Sano T, Katayama H,

Mizusawa J, Sasako M,

Katai H, Tanaka Y,

Kinoshita T, Terashima M,

Nashimoto A, Yamaue H,

Fukushima M, Yamada M,

Fujiwara Y, Kimura Y,

Azuma T, Yoshimura T

A phase II study of neoadjuvant

chemotherapy (NAC) with

docetaxel, cisplatin, and S-1

(DCS) followed by gastrectomy

with D2 plus para-aortic lymph

node (PAN) dissection for

gastric cancer with extensive

lymph node metastasis (ELM):

Japan Clinical Oncology Group

study JCOG1002

The 11th International Gastric

Cancer Congress (IGCC)

Sao

Paulo

(Brazil)


6 Yoshikawa T Fujitani K, Nishikawa K,

Tanabe K, Ito S, Matsui T,

Miki A, Nemoto H,

Sakamaki K, Cho H,

Fukunaga T, Kimura Y,

Hirabayashi N

Comparison of

chemotherapy-related

toxicities in a randomized 2X2

phase II trial comparing two and

four courses of cisplatin/S-1

(CS) and

docetaxel/cisplatin/S-1 (DCS)

as neoadjuvant chemotherapy

for locally advanced gastric

cancer

The European Cancer

Congress 2015

Vienna

(Austria)


7 Terashima M Iwasaki Y, Mizusawa J,

Katayama H, Nakamura K,

Katai H, Yoshikawa T, Ito S,

Kaji M, Kimura Y, Hirao M,

Yamada M, Kurita K,

Takagi M, Goto M,

Takagane A, Yabuzaki H,

Hirabayashi N, Sano T,

Sasako M

Randomized phase III trial of

gastrectomy with or without

neoadjuvant S-1 plus cisplatin

for type 4 or large type 3 gastric

cancer; short-term safety and

surgical results: Japan Clinical

Oncology Group Study (JCOG

0501)

The European Cancer

Congress 2015

Vienna

(Austria)


市立吹田市民病院


1 Tsuji Y Yamazaki K, Oba MS, Sakai

K, Nagase M, Ueda S,

Tamagawa H, Tamura T,

Moriwaki T, Murata K, Taira

K, Denda T, Funai S, Tsuda

T, Tsushima T,

Boku N, Hyodo I, Yamanaka

T, Tsurutani J, Nishio K, for

the West Japan Oncology

Group

Predictive biomarker analysis of

early tumor shrinkage induced

by FOLFIRI+Bev for patients

with metastatic colorectal

cancer in WJOG4407G study


2015

Vienna,

Austria

2015 9 Poster

市立豊中病院


1 Noda T. Hatano H.,Shimizu J.,

Dono K.

LAPAROSCOPIC

CHOLECYSTECTOMY TO

TORSION OF THE

GALLBLADDER,COMPARISON

TO OPEN

CHOLECYSTECTOMY:A

SINGLE-INSTITUTION

EXPERIENCE

5th Biennial Congress of the

Asian-Pacific

Hepato-Pancreato-Biliary

Association

SINGAPORE 2015 3 示説

2 Shinke G. Noda T.,Hatano H.,

Shimizu J.,Takata A.,

Hirota M.,Tanida T.,

Komori T.,Morita S.,

Imamura H.,

Iwazawa T. Dono K.

SURGICAL OUTCOME OF

LAPAROSCOPIC

CHOLECYSTECTOMY FOR

ACUTE CHOLECYSTITIS

PROGRESSING MORE THAN

72 H AFTER THE ONSET

5th Biennial Congress of the

Asian-Pacific


Association

SINGAPORE 2015 3 示説

大阪府立急性期・総合医療センター


1 Fujitani K Shishido Y, Yamamoto K,

Hirao M, Tsujinaka T,

Sekimoto M

C-reactive protein on

postoperative day 3 as a

predictor of infectious

complications following gastric

cancer resection

2015 Gastrointestinal Cancers

Symposium

San

Francisc

o

2015 1 Poster

2 Matsuda Chu Danno K, Miyazaki S,

Fujitani K, Kubota M,

Kawada J, Okumura Y,

Nomura M, Iwase K, Tanaka

Y

ROBOTIC SURGERY FOR

RECTAL CANCER:THE FIRST

30 RESECTION

SAGES 2015 Nashvill

e,TN

2015 4 Poster

3 Makihara K Azuma S, Ueno H, Nakata I,

Yamamoto K, Nishikawa K,

Hirao M, Fujitani K,

Tsujinaka T





Symposium

San

Francisc

o

2015 1 Poster

4 Hasegawa H Fujitani K, Sugimoto A,

Nakazuru S, Hirao M,

Tsujinaka T. Mita E

Optimal indications for palliative

chemotherapy in elderly

patients with metastatic or

recurrent gastric cancer


Symposium

San

Francisc

o

2015 1 Poster

5 Sano T Sasako M, Mizusawa J,

Katayama H, Katai H,

Yoshikawa T, Ito S, Kaji M,

Imamura H, Fukushima N,

Fujitani K, Iwasaki Y,

Kinoshita T

Randomaized controlled trial to

evaluate splenectomy in total

gastreetomy for proximal

gastric

carcinoma(JCOG0110):Final

survival analysis


Symposium

San

Francisc

o

2015 1 Poster

6 Yoshikawa T Tanabe K, Nishikawa

K,Fujitani K, Ito Y, Matsui T,

Hayashi T, Aoyama T, Cho

H, Morita S, Miyashita Y,

Tsuburaya A, Sakamoto J

A randmaized 2X2 phase Ⅱtrial

comparing two and four course

of S-1/cisplatin(SC) and

paclitaxel/cisplatin(PC) as

neoadjuvant chemotherapy for

locally resectable advanced

gastric cancer:Survival results

of COMPASS


Symposium

San

Francisc

o

2015 1 Poster

7 Takahashi M Tsuburaya A, Nishikawa K,

Tanabe K, Yamaguchi K,

Yoshino S, Namikawa T,

Yoshikawa T, Rino Y,

Kawada J, Tsujii A, Taira K,

Kawabata R, Kodera Y,

Hirashima Y, Yabusaki H,

Hirabayashi N, Fujitani K,

Morita S, Sakamoto J

A Phase Ⅱtrial of

capecitabine plus cisplatin(XP)

for patients with advanced

gastric cancer who relapsed

after S-1 adjuvant therapy, XP

after TS-1 adjuvant

failure(XparTS)


Symposium

San

Francisc

o

2015 1 Poster

8 Murata A Yoshida K,Maeda K,.Ikejiri

K,Munemoto Y,Sasaki

K,Matsuda C,Kotake

M,Suenaga T,Matsuda

H,Baba H,Hamada C,Oki

E,Emi Y,Saji S,Maehara Y

A Randomaized PhaseⅢTrial

Comparing S-1 versus UFT as

Adjuvant Chemotherapy for

Stage Ⅱ/Ⅲ Rectal

Cancer(JFMC35-C1:ACTS-RC)

ASCO 2015 Chicago 2015 5 Poster

大阪府立成人病センター


1 Ohue M Noura S, Miyoshi N,

Fujino S, Yasui M

Lower rectal cancer surgery

focusing on lateral lymph node

dissection

The 11th Shanghai

International Colorectal

Cancer Symposium

Shangha

i

2015 6 Moderators

2 Ohue M How to deal with liver

metastasis from colorectal

cancer in Japan

DREAM investigators' meeting

in ECCO 2015

Vienna 2015 9 Lecture

3 Noura S Imada S,Ohue M,

Miyoshi M

Efficacy of subcutaneous

penrose drains for surgical site

infections in colorekutal

surgery


of the E.A.E.S

Buchare

st,Roma

nia

2015 6 Oral

4 Kobayashi S Kanai M, Hatano E,

Fujiwara Y,

Marubashi S,Miyamoto A,

Shiomi H,Kubo S,

Ikuta S,Yanagimoto H,

Terajima H,Ikoma H,Sakai

D,Kodama Y,Seo S,

Morita S,Ajiki T,

Nagano H,Ioka T

A multi-institution Phase II

study of

gemcitabine/cisplatin/s-1

(GCS) combination

chemotherapy for patients with

advanced biliary tract cancer

(KHBO1002)

EASL 2015/ILC 2015

第 50 回欧州肝臓学会議/国

際肝臓学会議

Vienna,

Austria

2015 4 invited lecture

5 Miyoshi N Ohue M,Yasui M Preoperative treatment for

rectal cancer

11th International Colorectal

Cancer Symposium

Shangha

i,Chaina


6 Miyoshi N Miyoshi N, Ohue M,

Yasui M, Noura S,

Shingai T, Sugimura K,

Akira T, Akita H,

IKobayash S, Takahashi H,

Marubashi S,

Fujiwara Y,

Higashiyama M, Yano M

Novel prognostic prediction

models for patients with stage

IV colorectal cancer after

concurrent curative resection

ESMO Asia Singapor

e


7 Akagi T Inomata M,

Katayama H,

Mizusawa J,

Yamaguchi T,

Masaki T,

Fukunaga Y,

Murata K,

Okajima M,

Munakata Y,Sato T,

Bandou H,

Yasui M,

Sekimoto M,

Watanabe M,

Sugihara K,Konishi F,Etoh

T,Shimada Y,Kitano S

A randomized controlled trial to

evaluate laparoscopic versus

open with Japanese D3

dissection for stage II,III

colorectal cancer (CRC): First

efficacy results from Japan

Clinical Oncology Group Study

JCOG0404.

2015 ASCO annual Meeting Chicago,

America

2015 5,6 commentator

8 Ito Y Miyashiro I,

Hattori M,Nishino Y,

Ioka A,Nakayama T,

Rachet B.

Trends in cure proportion of

major cancer sites in

Japan:1993-2006(J-CANSIS

study):an observational study

Asian Oncology Summit 2015 Shangha

i,Chaina


国立病院機構大阪医療センター


1 Ikeda M Yamanaka T, Yamazaki K,

Yamaguchi K, Muro K,

Kusumoto T, Uetake H,

Sato T, Kato T, Nishina T,

Kanazawa A, Oki E,

Calvin C, Tara M,

Jayadevi K, Akagi K,

Ochiai A, Ohashi Y,

Ohtsu A, Yoshino T

Validation study of the 12-gene

Recurrence Score (RS) in

patients (pts) with stage II and

III colon canceｒ（CC) without

adjuvant chemotherapy;

SUNRISE Study

ESMO GI 2015 Barcelo

na

2015 7 示説

2 Ikeda M Sekimoto M, Miyake M,

Haraguchi N, Miyazaki M,

Miyamoto A, Hirao M,

Nakamori S

LAPAROSCOPIC SURGERY

FOR LOCALLY RECURRENT

RECTAL CANCER. REPORT

OF AN EARLY RESULTS


Surgery

Bangkok 2015 8 示説

3 Miyamoto A Maeda S, Hama N,

Yamamoto K, Miyake M,

Nishikawa K, Ikeda M,

Hirao M, Sekimoto M,

Nakamori S

IMPACT OF VISCERAL

OBESITY ON

PANCREATICODUODENECTO

MY

A-PHPBA 2015 Singapor

e

2015 3 示説

4 Nishikawa K Imamura H,Kawase T,

Gotoh M, Kimura Y,

Ueda S, Matsuyama J,

Kawada J, Sugimoto N,

Fujita J, Tamura T,

Fukusima N, Sakai D,

Shimokawa T, Kurokawa Y,

Satoh T, Tsujinaka T,

Furukawa H

A randomized phaseⅡfactorial

design trial of CPT-11 versus

PTX versus each combination

with S-1 in patients with


refractory to S-1: Final results

of OGSG0701.

ASCO-GI San

Francisc

o

2015 1 示説

5 Nishikawa K Nishida T, Takahashi T,

Akamaru Y, Omori T,

Mikata S, Yamamura N,

Doki Y

A PROSPECTIVE

RANDOMIZED TRIAL:

EFFECTS OF DAIKENCHUTO

ON INTESTINAL MOTILITY

AFTER TOTAL

GASTRECTOMY


Surgery


6 Nishikawa K Nishikawa K, Yaoshino S,

Morita S, Takahashi T,

Sakata K, Nagao J,

Nemoto H, Murakami N,

Matsuda T, Hasegawa H,

Shimizu R, Yoshikawa T,

Osanai H, Imano M,

Naitoh H, Yabe M,

Tanaka A, Sakamoto J,

Saji S, Oka M

A randomized phase Ⅲ study

of S-1 alone versus S-1 plus

immunomodulator lentinan for

unresectable or recurrent

gastric cancer (JFMC36-0701)

ESMO/ECC 2015 Vienna 2015 9 示説

7 Yamamoto K Fukuda Y, Tsujinaka T,


Nagatsuma Y, Nakayama T,

Tanikawa S, Maeda S,

Miyake M, Hama N,

Miyamoto A, Ikeda M,

Nakamori S, Sekimoto M

SARCOPENIA IS ASSOCIATED

WITH SEVERE

POSTOPERATIVE

COMPLICATIONS IN ELDERLY

GASTRIC CANCER PATIENTS

UNDERGOING

GASTRECTOMY

37th ESPEN Congress Lisbon 2015 9 示説

8 Uemura M Munakata K, Nishimura J,

Hata T, Takemasa I,

Mizushima T, Yamamoto H,

Doki Y, Mori M

Low proteasome activity and

cancer stemness in colorectal

cancer

AACR Annual Meeting Philadel

phia

2015 4 示説

9 Harada Y Ikeda M, Sekimoto M,

Miyake M, Haraguchi N,

Miyazaki M, Hirao M,

Nakamori S

RESECTION OF LUNG

METASTASIS INCREASES THE

PROGNOSIS OF PATIENTS

AFTER CURATIVE RESECTION

OF LOCALLY RECURRENT

RECTAL CANCER


Surgery


10 Fukuda Y Yamamoto K, Tsujinaka T,

Nishikawa K

OPTIMAL PREOPERATIVE

NUTRITIONAL SUPPORT FOR

MALNOURISHED PATIENTS

WITH GASTRIC CANCER

UNDERGOING

GASTRECTOMY

37th ESPEN Congress Lisbon 2015 9 示説

11 Yoshikawa T Tanabe K, Nishikawa K,

Fujitani K, Ito Y, Matsui T,

Hayashi T, Aoyama T,

Cho H, Morita S,

Miyashita Y, Tsuburaya A,

Sakamoto J

A randomized 2X2 phase II trial

comparing two and four courses

of S-1/cisplatin (SC) and

paclitaxel/cisplatin (PC) as


locally resectable advanced

gastric cancer: Survival results

of COMPASS

ASCO-GI San

Francisc

o

2015 1 示説

12 Masuishi T Kawase T, Nishikawa K,

Kunisaki C, Matsusaka S,

Segawa Y, Nakamura M,

Sasaki K, Nagao N, Tsuji A,

Yuasa Y, Asami S,

Takeuchi M, Furukawa H,

Fujii M., Nakajima T

Multicenter phase II study of

trastuzumab with S-1 alone in

elderly patients with HER-2

positive advanced gastric

cancer (JACCRO GC-06).

ASCO-GI San

Francisc

o

2015 1 示説

13 Kobayashi M Tsuburaya A, Nishikawa K,

Kawada J, Namikawa T,

Fukushima R, Kojima H,


Yoshino S, Takahashi M,

Hirabayashi N, Sato S,

Nemoto H, Rino Y,

Yoshikawa T, Nakajima J,


A randomized phase II trial of

capecitabine plus cisplatin (XP)

versus S-1 plus cisplatin (SP)

as a first-line treatment for

advanced gastric cancer: XP

ascertainment versus SP

randomized PII trial (XParTS II)

ASCO-GI San

Francisc

o

2015 1 示説





Kawada J, Tsuji A, Taira K,


Hirashima Y, Yabusaki Y,

Hirabayshi N, Fujitani K,


A phase II trial of capecitabine

plus cisplatin (XP) for patients

with advanced gastric cancer

who relapsed after S-1 adjuvant

therapy, XP after TS-1 adjuvant

failure (XParTS).

ASCO-GI San

Francisc

o

2015 1 示説

15 Makihara K Makihara K, Azuma S,

Ueno H, Nakata I,

Yamamoto K, Nishikawa K,

Hirao M, Fujitani K,

Tsujinaka T




patients

ASCO-GI San

Francisc

o

2015 1 示説

16 Miura Y Takano T, Sukawa Y,

Nosho K, Hironaka S,

Mori M, Nishikwa K,

Tokunaga S, Okuda H,

Tsuda M, Taku K,

Nishikawa K, Moriwaki T,

Yoshimura K, Boku N,

Hyodo I

A phase II trial of 5-weekly S-1

plus cisplatin (CDDP)

combination with trastuzumab

(Tmab) for HER2-positive

advanced gastric or

esophagogastric junction (EGJ)

cancer: WJOG7212G

(T-SPACE) study.

ASCO-GI San

Francisc

o

2015 1 示説

17 Yoshikawa T Tanabe K, Ito Y,

Nishikawa K, Fujitani K,

Matsui T, Hayashi T,

Aoyama T, Cho H, Morita S,

Miyashita Y, Tsuburaya A,

Sakamoto J

Subset analysis of COMPASS:

A randomized 2X2 phase II trial

comparing two and four courses

of S-1/cisplatin (SC) and

paclitaxel/cisplatin (PC) as


locally advanced gastric cancer.

ASCO Ｃｈｉｃａｇ

ｏ

2015 5 示説

18 Hiki N Yoshikawa T, Sakamaki K,

Ito S, Fujitani K,

Takigichi N, Kawashima Y,

Nishikawa K, Sasako M,

Ida S, Aoyama T, Honda M,

Sato T, Nunobe S, Cho H

A phase III trial to confirm

preventing effects of

perioperative enteral

EPA-enriched immunonutrition

on body weight loss after total

gastrectomy for gastric cancer


19 Yoshikawa T Fujitani K, Nishikawa K,

Tanabe K, Ito S, Matsui T,

Miki A, Nemoto H,

Sakamaki K, Cho H,

Fukunaga T, Kimura Y,

Hirabayashi N

Comparison of

chemotherapy-related

toxicities in a randomized 2X2

phase II trial comparing two and

four courses of cisplatin/S-1

(CS) and

docetaxel/cisplatin/S-1 (DCS)

as neoadjuvant chemotherapy

for locally advanced gastric

cancer


20 Tsuburaya A Nishikawa K,

Kobayashi M, Kawada J,

Namikawa T, Fukushima R,

Kojima H, Tanabe K,

Yamaguchi K, Yoshino S,

Takahashi M,

Hirabayashi N, Sato S,

Nemoto H, Rino Y,

Yoshikawa T, Nakajima J,

Morita S, P Tan,

Sakamoto J

Molecular biomarker study in

randomized phase II trial of

capecitabine plus cisplatin

versus S-1 plus cisplatin as a

first-line treatment for

advanced gastric cancer:

XParTS Iib

ESMO Asia 2015 Singapor

e

2015 12 示説

21 Morimoto M Ikeda M, Shimizu S,

Inaba Y, Kojima Y,

Hagihara A, Kudo M,

Nakamori S, Kaneko S,

Sugimoto R, Tahara T,

Ohmura T, Yasui K, Sato K,

Ishii H, Furuse J,

Okusaka T.

A randomized phase 2 trial of

sorafenib plus intra-arterial

cisplatin versus sorafenib alone

for advanced hepatocelluiar

carcinoma.

ILCA2015 Paris 2015 9 示説

22 Yanagimoto H Okusaka T, Ishii H,

Furuse J, Ohkawa S,

Fukutomi A, Ioka T, Sho M,

Nakamori S, Kitano M,

Sugimori K, Maguchi H,

Imaoka H, Baba H,

Shimizu A, Yokota I,

Ohashi Y, Yamaue H.

Interim safety analysis of a

randomized phase II trial

comparing alternate-day oral

therapy using S-1 with the

standard regimen as a first-line

treatment for patients with

advanced pancreatic cancer.

ASCO 2015 Chicago 2015 5 誌上発表

23 Ikeda M Shimizu S, Sato T,

Morimoto M, Inaba Y,

Kojima Y, Hagihara A,

Kudo M, Nakamori S,

Kaneko S, Sugimoto R,

Tahara T, Ohmura T,

Yasui K, Sato K, Ishii H,

Furuse J, Okusaka T.

Sorafenib plus intra-arterial

cisplatin versus sorafenib alone

in patients with advanced

hepatocellular carcinoma: A

randomized phase II trial.

ASCO 2015 Chicago 2015 5 示説

24 Fukutomi A Mizusawa J, Katayama H,

Nakamura S, Ito Y,

Hiraoka N, Ioka T, Ueno M,

Ikeda M, Sugimori K,

Shimizu K, Okusaka T,

Ozaka M, Yanagimoto H,

Nakamori S, Azuma T,

Hosokawa A, Sata N,

Mine T, Furuse J.

Randomized phase II study of

S-1 and concurrent

radiotherapy with versus

without induction chemotherapy

of gemcitabine for locally

advanced pancreatic cancer

(JCOG1106).

ASCO 2015 Chicago 2015 5 示説

25 Sasaki Y Akasu T, Saito N, Kojima H,

Matsuda K, Nakamori S,

Komori K, Amagai K,

Yamaguchi T, Nagashima K,

Okita N, Yamada Y.

Impact of KRAS/NRAS

mutation status on the

outcomes of patients with stage

III colorectal cancer: Correlative

study in NSAS-CC/RC.

18th ECCO

40th ESMO

Vienna 2015 9 示説

26 Honda K Kobayashi M, Okusaka T,

Nakamori S, Shimahara M,

Ueno, T, Tsuchida A,

Sata N, Ioka T, Yasunami Y,

Masaru Y, Kosuge T,

Jung G, Yamada T.

Plasma biomarker for detection

of early stage pancreatic cancer

and risk factors for pancreatic

malignancy using antibodies

against apolipoprotein-AII

isoforms.

18th ECCO

40th ESMO

Vienna 2015 9 示説

大阪労災病院


1 Kawabata R Sakai D, Kawada J,

Nishikawa K, Oka Y,

Sugimoto N, Shimizu T,

Nishijima J, Hasegawa H,

Endo S, lsozaki Y,

Kimura Y, Matsuyama J,

Kurokawa Y, Shimokawa T,

Fujitani K, Sato T

A Phase Trial Trastuzumab

Combined with lrinotecan in

Patienrs with Advanced

HER2-positive

Chemo^refractory Gastric

Cancer:Osaka Gastrointestinal

Cancer Chemotherapy Study

Group OGSG1203(HERBIS-5)

ESMO ASIA 2015 Singapore 2015 12 示説





Kawada J, Tsiji A, Taira K,


Hirashima Y, Yabusaki H,

Hirabayashi N, Fujitani K,


A phase Ⅱ trial of

capecitabone plus cisplation

(XP)for patients with advanced

gastric cancer who relapsed

after S-1 adjuvant therapy, XP

after TS-1 adjuvant

failure:(XParTS)

ASCO-GI 2015 San

Francisco

2015 1 示説

関西ろうさい病院


1 Tamura S Takeno A, Murakami K,

Naito A, Katsura Y,

Ohomura Y, Kagawa Y,

Okishiro M, Egawa C,

Takeda Y, Kato T

Results of the preoperative

diagnosis by staging

laparoscopy and the surgical

intervention following

chemotherapy for patients with

peritoneal dissemination due to

gastric cancer

ESMO Vienna 2015 9 示説

2 Takeda Y Wakasugi M, Shimizu J,

Noda T, Yamamoto T,

Oshima S, Eguchi H,

Mori M, Doki Y, Nagano H

Lack of efficacy of preoperative

dexamethasone for

postoperative nausea and

vomiting after laparoscopic

cholecystectomy: a large-scale,

multicenter, randomized,

double-blind,

placebo-controlled trial in

Japan (CSGO-HBP-002)

The 5th Biennial Congress of

the Asian-Pacific


Association

Singapore 2015 3 口演

3 Hamaguchi T Shimada Y, Mizusawa J,

Kinugasa Y, Kanemitsu Y,

Ohue M, Fujii S,

Takiguchi N, Yatsuoka T,

Takii Y, Ojima H, Masuko H,

Kubo Y, Mishima H,

Yamaguchi T, Bandou H,

Sato T, Kato T,

Nakamura K, Fukuda H

Randomized phase III study of

adjuvant chemotherapy with

S-1 versus capecitabine (cape)

in patients with stage III colon

cancer (CC): Results of Japan

Clinical Oncology Group study

(JCOG0910).

2015 ASCO Annual Meeting Chicago 2015 6 示説

西宮市立中央病院


1 Endo S Yamada T, Ikenaga M,

Konishi K, Ohta K,

Nakagawa T, Nakashima S,

Kobayashi I, Sasaki K,

Nishijima J

Prognostic factors of oral intake

after endoscopic

gastroduodenal stent placement

for advanced gastric cancer




Daegu,

Korea

2015 9 oral

兵庫県立西宮病院


1 Fukunaga M Nishimura J, Satoh T,

Takemoto H, Nakata K,

Ide Y, Fukuzaki T, Kudo T,

Miyake Y, Yasui M,

Morita S, Sakai D,

Uemura M, Hata T,

Takemasa I, Mizushima T,

Ohno Y, Yamamoto H,

Sekimoto M, Nezu R,

Doki Y, Mori M

A phase III trial of aprepitant in

colorectal cancer patients

receiving oxaliplatin-based

chemotherapy (SENRI Trial)

The MASCC（Multinational

Association of Supportive

Care in Cancer）/ISOO 2015

Annual Meeting

Copenh

agen

2015 6 示説

独立地方行政法人りんくう総合医療センター


1 Nakamura K Iiboshi Y, Fukui M, Ito T,

Izukura M

The Layers of Appendiceal Wall

and Abscess Size Change as

Reasonable Factors to Assess

the Efficacy of Conservative

Therapy for Appendicitis with

Abscess Formation

9th Annual Conference of

Cambodian Society of

Pediatric Surgery

Cambodi

a

2015 11 Oral

豊中緑ヶ丘病院


1 Shuji Saito Hitoshi Sekido,

Shuntaro Yoshida,

Hiroyuki Isayama,

Takeaki Matsuzawa,

Toshio Kuwai,

Iruru Maetani,

Mamoru Shimada,

Tomonori Yamada,

Masafumi Tomita,

Koichi Koizumi,

Nobuto Hirata,

Hideki Kanazawa,

Satoshi Ikeda, Ken Konishi,

Tomio Hirakawa, Rika Kyo,

Toshiyuki Enomoto,

Yoshihisa Saida

A prospective multicenter

study of self-expandable

metallic stents as a bridge to

surgery for malignant colorectal

obstruction in Japan: efficacy

and safety in 313 patients

Society of American

Gastrointestinal and

Endoscopic Surgeons 2015

Nashvill

e, TN,

USA

2015 4 Oral

大阪大学消化器外科 - Osaka University...tumor thrombus in the major trunk. 2015 Shanghai...

Documents

Transcript of 大阪大学消化器外科 - Osaka University...tumor thrombus in the major trunk. 2015 Shanghai...

大阪大学 消化器外科 - Osaka University...tumor thrombus in the major trunk. 2015 Shanghai...

Documents

Transcript of 大阪大学 消化器外科 - Osaka University...tumor thrombus in the major trunk. 2015 Shanghai...

大阪大学消化器外科 - Osaka University...tumor thrombus in the major trunk. 2015 Shanghai...

Transcript of 大阪大学消化器外科 - Osaka University...tumor thrombus in the major trunk. 2015 Shanghai...